| Literature DB >> 34697850 |
Marijanne Engel1, Annemieke van der Padt-Pruijsten2, Auke M T Huijben2, T Martijn Kuijper3, Maria B L Leys2, Annemieke Talsma4, Agnes van der Heide1.
Abstract
OBJECTIVE: For patients who are discharged to go home after a hospitalisation, timely and adequately informing their general practitioner is important for continuity of care, especially at the end of life. We studied the quality of the hospital discharge letter for patients who were hospitalised in their last year of life.Entities:
Keywords: cancer; continuity of patient care; end-of-life care; general practitioners; hospital; hospital discharge letter
Mesh:
Year: 2021 PMID: 34697850 PMCID: PMC9285046 DOI: 10.1111/ecc.13524
Source DB: PubMed Journal: Eur J Cancer Care (Engl) ISSN: 0961-5423 Impact factor: 2.328
FIGURE 1Flow chart of inclusion
Patients' demographics and disease characteristics
| Total ( | ||
|---|---|---|
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
| |
|
|
|
|
|
|
| |
|
|
| |
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
Information present in the hospital discharge letter
| Items addressed in the hospital discharge letter |
|
|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For 35 patients (32.4%), the information in the discharge letter about the entry route for hospitalisation was clear; for 24 patients (22.2%), it was not clear; for 49 patients (45.4%), the discharge letter included no information about the patient's entry route for hospitalisation.
For 19 patients (17.6%), medication was stopped during the hospital admission, but this was not mentioned in the discharge letter. For 12 patients (11.1%), no medication was stopped during the hospital admission, and no information was mentioned in the discharge letter.
Extent to which patients' limited life expectancy was addressed in the medical record and hospital discharge letter
| Items addressed | In hospital medical record | In hospital discharge letter |
|---|---|---|
|
| ||
|
|
|
|
|
Prognosis: | ||
|
Yes, by indicating a life expectancy of max. days/weeks/months/1 year |
|
|
|
Yes, by indicating that care was oriented at symptom control or palliative needs |
|
|
|
No |
|
|
|
Discussion of preferences for treatment and care with patient and/or family |
|
|
|
| ||
|
Potential treatment limitation or discontinuation |
| |
|
Symptom control/comfort care |
| |
|
|
| |
|
|
| |
|
Agreements made with patient and/or family about treatment limitations |
|
|
|
| ||
|
Do‐Not‐Resuscitate |
|
|
|
No artificial respiration |
|
|
|
No ICU admission |
|
|
|
Comfort care only |
|
|
|
Other |
|
|
|
Advance care directive(s) completed by patient |
|
|
Multiple answers possible.
‘Other’ includes no antitumor treatment, no treatment of infections, no dialysis, no blood transfusion, no defibrillation, no readmission to the hospital and no life‐prolonging treatment.
Extent to which patients' limited life expectancy was addressed in medical record and the hospital discharge letter according to patient characteristics
| Hospital medical record included information on patients' limited life expectancy | Hospital discharge letter included information on patients' limited life expectancy | ||||||
|---|---|---|---|---|---|---|---|
| Yes | No |
| Yes | No |
| ||
| Age at death | 0.416 | 0.508 | |||||
| Up to 80 years ( | 51 (68.0) | 24 (32.0) | 38 (50.7) | 37 (49.3) | |||
| 80 years and older ( | 25 (75.8) | 8 (24.2) | 19 (57.6) | 14 (42.4) | |||
| Diagnosis | 0.616 | 0.090 | |||||
| Cancer ( | 42 (72.4) | 16 (27.6) | 35 (60.3) | 23 (39.7) | |||
| Non‐cancer ( | 34 (68.0) | 16 (32.0) | 22 (44.0) | 28 (56.0) | |||
| Hospital admission was | 0.062 | 0.125 | |||||
| Unplanned ( | 66 (74.2) | 23 (25.8) | 50 (56.2) | 39 (43.8) | |||
| Planned ( | 10 (52.6) | 9 (47.4) | 7 (36.8) | 12 (63.2) | |||
| Reason for hospitalisation | 0.086 | 0.116 | |||||
| Symptom management ( | 67 (73.6) | 24 (26.4) | 51 (56.0) | 40 (44.0) | |||
| Other ( | 9 (52.9) | 8 (47.1) | 6 (35.3) | 11 (64.7) | |||
| Duration of hospital admission in days | 0.520 | 0.408 | |||||
| 1–6 days ( | 40 (67.8) | 19 (32.2) | 29 (50.9) | 30 (50.8) | |||
| 7 days and longer ( | 36 (73.5) | 13 (26.5) | 28 (57.1) | 21 (42.9) | |||
| Survival after hospital admission | 0.000 | 0.007 | |||||
| 0–3 months ( | 50 (90.9) | 5 (9.1) | 36 (65.5) | 19 (34.5) | |||
| 3–12 months ( | 26 (49.1) | 27 (50.9) | 21 (39.6) | 32 (60.4) | |||
Pearson's chi‐squared test.